Price Alert: Shares of Xenon (XENE) Trade 8.05% Higher at Midday June 21

Equities Staff  |

Xenon Pharmaceuticals Inc (NASDAQ: XENE) shares have risen 8.05%, or $2.455 per share, as on 12:13:07 est today. Opening the day at $31.22, 318,646 shares of Xenon have traded hands and the stock has traded between $33.61 and $31.00.  

So far this year the company is down 2.43%.

Xenon anticipates its next earnings on 2022-08-11.

For technical charts, analysis, and more on Xenon visit the company profile.

About Xenon Pharmaceuticals Inc

Xenon is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. The Company is advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy.

To get more information on Xenon Pharmaceuticals Inc and to follow the company's latest updates, you can visit the company's profile page here: Xenon Pharmaceuticals Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

The Best Laid Plans of Mice and Men — Part II
Why I’m Buying the 'New' Value Stocks
Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade



Market Movers

Sponsored Financial Content